Ethereum enters February 2026 under pressure, testing key support near $2,690 after a historically weak January. Analysts are divided on whether seasonal trends or shifting on-chain dynamics will dictate the month's direction.
The Institute of Chartered Accountants of Scotland launches its 2026 CA Rising Stars search, introducing a new 'Community and Social Value' award to recognize young professionals driving ethical and technological change in the field.
As data center demand surges, NextEra Energy emerges as a critical, and often overlooked, infrastructure player. Its partnerships with tech titans like Meta and Google highlight a strategic pivot in the energy sector.
As Peloton Interactive prepares to report its Q2 fiscal 2026 results, investors are scrutinizing whether the fitness company's aggressive cost-cutting can finally fuel a sustainable turnaround, despite shares languishing 96% below their peak.
The resignation of Prudential Financial's Japan life insurance CEO following a widespread employee misconduct scandal has triggered governance reviews and shaken investor confidence in one of the insurer's key international markets.
Argenta Silver Corp. sees its stock decline following the announcement of a new mineral discovery at its El Quevar project in Argentina and the completion of a substantial equity financing, highlighting the complex calculus investors face with junior mining explorers.
At its Perform conference, Dynatrace unveiled Dynatrace Intelligence, a new platform merging deterministic and agentic AI to automate complex IT operations. The launch, coupled with enhanced cloud integrations and user monitoring tools, signals the company's aggressive push to dominate the observability market in an AI-driven era, even as some debate its current market valuation.
The U.S. dollar and Treasury yields advanced amid reports President Trump is set to nominate former Fed Governor Kevin Warsh as the next central bank chief, a choice markets interpret as leaning hawkish and likely to slow the pace of interest rate cuts.
President Donald Trump is expected to nominate Kevin Warsh, a former Federal Reserve governor with a notably more open stance toward Bitcoin, to lead the central bank. The anticipated move has already triggered market reactions and reshaped expectations for U.S. monetary policy.
Solana's network is attracting new users at a rapid pace, adding over 10 million first-time transaction addresses daily. However, conflicting signals from ETF outflows and a cautious macro environment are testing whether this growth can fuel a sustained price rally for SOL.
Amidst market volatility, Coca-Cola (KO) stands out with its formidable brand moat and a 63-year dividend growth streak, offering investors a blend of stability and reliable income.
The Horatio Alger Award bestowed upon ResMed founder Dr. Peter Farrell underscores the company's decades-long leadership in sleep and respiratory care, bringing its financial performance and competitive strategy into sharper focus for investors.
Microsoft's second-quarter earnings smashed expectations, fueled by a 26% surge in cloud revenue that crossed the $50 billion mark for the first time. The tech giant's aggressive AI investments are now driving significant growth across its enterprise stack.
AMD and GIGABYTE have significantly expanded their partnership to co-develop a new generation of AI-accelerated gaming laptops, motherboards, and monitors. This strategic move aims to bring powerful, on-device AI capabilities directly to consumers, potentially reshaping competitive dynamics in the PC gaming hardware market.
Shares of the building products manufacturer have retreated from recent highs, presenting investors with a valuation puzzle. While a key cash flow model suggests the stock is undervalued, its premium P/E ratio tells a more cautious story. We break down the conflicting signals.
In its Q4 2025 earnings call, SL Green Realty projected strong fundamentals for Manhattan's office market, citing robust leasing and AI-driven demand. Management reiterated ambitious 2026 financing and asset sale targets while reporting quarterly results that beat expectations.
Goldman Sachs has upgraded BioNTech SE (NASDAQ:BNTX) from Neutral to Buy, raising its price target to $142. The firm highlights the company's pivotal role in next-generation cancer treatments, including immuno-oncology and antibody-drug conjugates (ADCs), as a major catalyst for future growth.
UBS has increased its price target for digital transformation leader Globant to $75, forecasting a period of stabilized, if modest, growth for the IT services sector next year despite near-term revenue headwinds.
Biotech firm Argenx SE sees its flagship drug Vyvgart outperform sales expectations in myasthenia gravis and CIDP treatments, with analysts pointing to sustained growth and regulatory momentum as key drivers.
As demand for specialist education soars, private investors—from Abu Dhabi to private equity firms—are capitalizing on a strained system, drawing criticism for extracting profits from vulnerable children and cash-strapped councils.
